v3.26.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive income (loss)
Non- Controlling interest
Treasury shares
Total
Balance at Dec. 31, 2024 $ 90,083   $ 247,842,445 $ 1,230,511 $ (122,605,730) $ (14,919,345) $ (1,605,878) $ (4,066,610) $ 120,067,165
Balance (in Shares) at Dec. 31, 2024 90,083,396 14,101,689              
Balance (in Shares) at Dec. 31, 2024               (144,206)  
Net income (loss)   (1,579,234) (471,748)   (2,050,982)
Exercise of stock options        
Exercise of stock options (in Shares) 472              
Share-based compensation for employee and director stock awards     27,066   27,066
Appropriation to statutory reserves   1,812,091 (1,812,091)  
Foreign currency translation adjustment   670,911 28,933   699,844
Balance at Mar. 31, 2025 $ 90,083   247,869,511 3,042,602 (125,997,055) (14,248,434) (2,048,693) $ (4,066,610) 118,743,093
Balance (in Shares) at Mar. 31, 2025 90,083,868 14,101,689              
Balance (in Shares) at Mar. 31, 2025               (144,206)  
Balance at Dec. 31, 2025 $ 88,646   248,500,176 3,042,602 (133,795,940) (13,112,769) (3,198,482) $ 109,479,591
Balance (in Shares) at Dec. 31, 2025 88,645,836 7,955,358             88,645,836
Balance (in Shares) at Dec. 31, 2025                
Net income (loss)   (9,287,372) 325,082   $ (8,962,290)
Share-based compensation for employee and director stock awards     443   443
Foreign currency translation adjustment   1,769,815 (78,787)   1,691,028
Balance at Mar. 31, 2026 $ 88,646   $ 248,500,619 $ 3,042,602 $ (143,083,312) $ (11,342,954) $ (2,952,187) $ 102,208,772
Balance (in Shares) at Mar. 31, 2026 88,645,836 7,955,358             88,645,836
Balance (in Shares) at Mar. 31, 2026